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Escherichia coli lysatesCell-free protein production has become a core technology in the rapidly spreading ﬁeld of synthetic
biology. In particular the synthesis of membrane proteins, highly problematic proteins in conven-
tional cellular production systems, is an ideal application for cell-free expression. A large variety
of artiﬁcial as well as natural environments for the optimal co-translational folding and stabiliza-
tion of membrane proteins can rationally be designed. The high success rate of cell-free membrane
protein production allows to focus on individually selected targets and to modulate their functional
and structural properties with appropriate supplements. The efﬁciency and robustness of lysates
from Escherichia coli strains allow a wide diversity of applications and we summarize current strate-
gies for the successful production of high quality membrane protein samples.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Membrane proteins are one of the most important protein
classes and they represent the majority of targets for modern
drugs. Numerous limitations in their production by conventional
in vivo expression systems largely retarded their functional and
structural characterization. Toxicity, limited membrane space for
their functional folding as well as inefﬁcient transport and mem-
brane insertion mechanisms pose signiﬁcant barriers. Synthetic
cell-free (CF) expression systems eliminate most of these classical
problems in membrane protein production and thus rapidly
became a new platform for their characterization [1–5]. In addi-
tion, CF expression uniﬁes a number of further beneﬁcial proper-
ties such as non-complicated operation, high success rates and
large ﬂexibility for the fast development of an array of diverse
applications [6].
CF expression is a relatively old technique and known since
more than 50 years after publication of the famous experiments
of Nirenberg and co-workers on deciphering the genetic code with
Escherichia coli lysates [7]. While the technique has been in use for
decades as analytical scale protein production system, the overall
synthesis efﬁciency was considerably improved after developing
reﬁned protocols and reaction designs [8,9]. Based on its easyaccess and excellent advantages for the efﬁcient labeling of
proteins, CF expression systems became routine platforms for the
production of soluble proteins for structural analysis [10–12]. In
recent times, the variation of CF systems rapidly expanded and
lysates of various organisms have been analyzed for their efﬁcien-
cies in protein production.
The available CF systems show tremendous differences in view
of efﬁciencies and applications and selection of appropriate CF
lysate sources can be crucial for the subsequent performance of a
project. At the current state of the art, lysates from E. coli have been
successfully used for the production of the by far highest variety of
membrane proteins with regard to size, topology, function and ori-
gin [13,14]. Documented applications include functional studies,
X-ray crystallography, nuclear magnetic resonance (NMR) struc-
tural analysis as well as the characterization of large membrane
protein assemblies [15–18]. Key advantage of E. coli lysates is their
reliable efﬁciency in protein synthesis allowing the routine pro-
duction of even large membrane proteins in mg amounts per one
mL of reaction. Detailed protocols for the preparation of E. coli
lysates and for the set-up of corresponding CF reactions have been
described [19–22]. CF membrane protein production was initiated
approximately 10 years ago and applications are continuously
expanding (Fig. 1). In parallel, the number of system variations
and protocols is still increasing. The intention of this review is to
give a guideline on what kind of decisions and considerations have
to be made when approaching the CF expression of a membrane
protein in E. coli lysates. Complementary information summarizing
current approaches can be obtained in several recent reviews [1,3–
Fig. 1. PubMed referenced reports on the CF expression of membrane proteins in
between 2004 and 2015.
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systems with linear or circular DNA as template. Transcription is
usually controlled by supplied T7 RNA polymerase which can be
isolated out of overexpressing strains according to routine proto-
cols [24]. Alternatively, E. coli lysates with already adjusted con-
centrations of T7 RNA polymerase are commercially available.
Expression controlled by endogenous E. coli RNA polymerases
could further be efﬁcient [15,25]. Protocols are developed and opti-
mized in small volumes of microplates and subsequent scaling up
to even multiple liter volumes is possible [26]. Expression efﬁcien-
cies close to one mg per mL are already possible with single com-
partment batch reactions and by using E. coli lysates from
optimized strains as well as speciﬁc reaction conditions [27–29].
Crude E. coli lysates can even be replaced by reconstituted transla-
tion machineries composed out of the puriﬁed individual compo-
nents [30].
Protein production efﬁciencies considerably increase by provid-
ing additional reservoirs of small molecule precursors in a second
compartment [9]. Protein synthesis in such continuous exchange
cell-free (CECF) conﬁgurations is ongoing for many hours.
Container geometry, the ratios of reaction and reservoir volume
as well as the exchange surface in between the two compartments
are important parameters that determine the ﬁnal protein produc-
tion efﬁciencies. A number of alternative options comprising indi-
vidual as well as commercially available CECF containers have
been proposed [22]. In addition, recently developed dialyzer car-
tridges in combination with standard deep-well microplates are
well suitable for analytical and semi-preparative scale screening
reactions in the CECF conﬁguration.
2. Project strategies: approaching CF production of membrane
proteins in E. coli lysates
CF expression can generally be considered as a complementary
approach to expression in E. coli cells in cases when the cellular
expression fails or only minute amounts of protein are synthesized
[13]. In addition it is a good choice for the quick labeling of a pro-
tein as DNA templates can easily be shuttled in between expres-
sion systems with E. coli cells or CF lysates. Initial considerations
when approaching CF expression should address (i) whether the
technique is generally appropriate for the production of the
selected target, (ii) which lysate should be used, (iii) which reac-
tion environments should be provided and (iv) how sample quality
can be controlled and evaluated (Fig. 2). Completely integral mem-
brane proteins are preferable and targets containing up to 12
transmembrane segments and exceeding 100kDa have been syn-
thesized so far [14,31]. In contrast, membrane proteins containing
large soluble domains such as anchored or single span membraneproteins are more likely to experience folding problems during CF
expression. Supplied detergents or other artiﬁcial hydrophobic
compounds may affect the proper folding of the soluble domains.
The presence of multiple disulﬁde bridges could furthermore cause
problems and the screening of redox systems should then be con-
sidered [32].
Common lysate sources are the E. coli K strain A19 or BL21
derivatives such as the strains C41 or C43 known as the gold stan-
dards for membrane protein production in vivo [33]. In addition to
different strains, also several modiﬁcations of lysate preparation
can be considered. Standard S30 lysates (i.e. fractionated by cen-
trifugation at 30000g) still contain residual cellular membrane
fragments in amounts of up to approximately 100 lg lipids per
one ml of lysate [18,34]. Inserted endogenous porins or ion chan-
nels may thus cause background signals when working with highly
sensitive detection methods such as electrophysiological measure-
ments. This background can be avoided by using S60 extracts pre-
pared at 60000g [34]. On the other hand, S12 extracts prepared at
12000g can be used alternatively to S30 extracts for other targets
[35]. Protein labeling might be performed in lysates of speciﬁcally
designed E. coli knock out mutants or in chemically pre-treated
lysates [36]. Lysates could further become enriched for chaperones
that might improve the functional folding of synthesized proteins
[37]. Chaperone induction upon lysate production or supply of
chaperones could alter the resulting lysate proteomes into more
favorable environments.
CF expression is a highly versatile synthetic biology approach.
Initial reaction designs can therefore be adjusted according to the
individual requirements of a membrane protein or to the intended
application (Fig. 2). Samples suitable for structural approaches can
be obtained by the co- or post-translational solubilization of CF
expressed membrane proteins in a number of detergents.
Numerous membrane proteins strictly require lipids in order to
support folding and stability [38,39]. Expression in presence of pre-
formed nanodiscs or with supplied detergent micelles containing
particular lipids will therefore be a good choice. The multitude of
options in order to manipulate reaction conditions will usually
generate a comprehensive library of samples containing the target
protein in quite different environments and probably also with sig-
niﬁcant variations in quality (Fig. 3). The strategy resembles the
classical ‘‘funnel’’ model of expression screens for membrane pro-
tein crystallization [40,41]. In cellular expression systems, large
target libraries are screened and selection by expression efﬁcien-
cies, membrane insertion and isolation procedures usually results
into a subset of few promising targets (Fig. 3). In contrast, a num-
ber of signiﬁcant differences do exist with the CF-funnel model.
First, the high success rate of CF expression allows focusing on
few selected targets that are of prime interest. Second, a large sam-
ple library of the desired target solubilized in a variety of different
environments is generated. Third and most important is that
screening tools mainly comprise additives affecting sample quality
such as folding environments composed out of various combina-
tions of hydrophobic compounds, stabilizers and ligands rather
than parameters affecting production efﬁciencies as in the classical
cellular funnel. The result of the CF-funnel model is therefore a
subset of samples having the desired and functionally folded target
in different environments such as detergent micelles or nanodiscs
(Fig. 3).
The functional folding of a membrane protein usually shows
more or less clear preferences for particular CF reaction environ-
ments [39,42]. Efﬁcient sample quality evaluation tools preferen-
tially applicable directly in the crude CF reaction mixture such as
speciﬁc ligand binding assays or enzymatic activity measurements
are therefore valuable. The availability of such tools is frequently a
major bottleneck in CF expression projects as only more advanced
and time consuming assays such as size exclusion proﬁling or
Fig. 2. Basic considerations important for the initial design of CF expression processes. Depending on the target properties and on the intended application, individual options
and modules will be selected for the design of the ﬁnal CF expression strategy.
Fig. 3. Schematic comparison of cellular versus CF screening strategies for membrane protein production. Both processes are compared as a ‘‘funnel’’ model. Symbols
represent the individual membrane protein targets. The main differences in between the two strategies exist in the target list and in the screening strategies as discussed in
the text. The CF funnel starts with one desired target represented by the star and generates a library of samples in a variety of different environments comprising hydrophobic
solubilizing compounds, stabilizers or ligands. In contrast, the cellular funnel starts with a larger list of different targets that will all be synthesized in identical or very similar
conditions. Quality control e.g. implementing functional assays will select a sample subset with the identical target solubilized in different environments in the cell-free
funnel, whereas a subset of different targets solubilized in identical environments are usually selected in the cellular funnel.
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short list of promising expression conditions can be determined
by using fusions with monitors such as green ﬂuorescent protein
(GFP) (Fig. 4) [43]. Reaction conditions resulting into aggregated
membrane proteins could then instantly be identiﬁed by using
fusions with C-terminally attached GFP derivatives [44,45].
Furthermore, concentration screens of compounds affecting yield
and solubilization of a membrane protein can rapidly be
monitored.
3. The ﬁrst milestone: improving CF production efﬁciencies of
membrane proteins
CF expression reactions have a largely reduced complexity if
compared with living cells as environment for protein overproduc-
tion. Cytotoxic effects are eliminated and the lysate preparation
procedure enriches compounds relevant for the expression
machinery. The open access furthermore facilitates the addition
of e.g. protease inhibitors in order to prevent the degradation of
synthesized proteins. As a result, expression problems such as
low yields are usually only associated with inefﬁcient translation
and can rapidly be addressed by few standardized optimization
steps. Adjusting the Mg2+ ion concentration for each DNA template
is always mandatory as a ﬁrst trouble shooting step and it has a
clear impact on the ﬁnal expression success [46,47]. Target frag-
mentation could be caused by premature termination of transla-
tion and may be addressed by using codon optimized synthetic
genes.
The initial DNA template design usually comprises a number of
alternative options that are either used for protocol development
or for ﬁnal preparative scale expressions (Fig. 4). Inefﬁcient initia-
tion of translation is the most frequently encountered bottleneck
when approaching high yield CF expression. Prime determinants
of translation initiation are the ﬁrst few codons of the mRNA and
suboptimal nucleotide sequences could restrict their access by ribo-
somal RNA subunits [48]. A rapid pragmatic approach in order to
improve expression yields is the attachment of short sequence opti-
mized N-terminal expression tags (Fig. 4) [49–51]. Screening a low
number of nucleotide-optimized expression tagsmostly results into
signiﬁcantly improved expression efﬁciencies within short time. If
the modiﬁcation of the target protein with the few amino acids of
the expression tag causes non-desired altered protein characteris-
tics, enrichment of the ﬁrst six to seven natural mRNA codons for
A or T nucleotides by directed mutagenesis will be an alternative
strategy as demonstrated with a membrane-integrated domain of
an ABC transporter [52]. Additional tags useful for rapid puriﬁcationFig. 4. Improving the CF expression yield of a membrane protein target. The basic
benchmarking. Adjusting the Mg2+ ion concentration for each target DNA template is furt
optimized by either addition of small expression tags or by appropriate silent mutag
attachment of C-terminal monitors such as GFP and of small standard puriﬁcation-tags.(i.e. poly(His)n-tags or Strep-tags) could be attached to the
C-terminus of the target protein (Fig. 4).
Further major determinants for the expression yield are (i) the
selected conﬁguration, i.e. batch versus CECF, (ii) the selected
energy resources and precursor concentrations and (iii) the precur-
sor reservoir volume in the CECF conﬁguration as well as its poten-
tial refreshing during the reaction. Yields of even identical targets
from different reports are therefore hard to compare as usually
quite different reaction conditions have been used. Examples of
detailed protocols and cost calculations for the preparative scale
production of membrane proteins intended for structural projects
have been published and could be taken as preliminary bench-
marks [18,22].
4. Reﬁning sample quality: designing synthetic environments
with additives
If the above mentioned optimization strategies are considered,
the success rate of membrane protein production in E. coli lysates
is very high and independent from membrane protein topology
or function. Based on the established production protocol, the sub-
sequent reﬁnement procedure will focus on the systematic screen-
ing of expression environments suitable to support the functional
folding and stability of the synthesized membrane protein
(Fig. 5). Three distinct expression modes can serve as starting
points for sample quality optimization. In the precipitate forming
(P-CF) mode, the synthesized membrane proteins precipitate after
translation and are solubilized post-translationally in detergent
micelles. In contrast, in the detergent-based (D-CF) and the
lipid-based (L-CF) modes, the synthesized membrane proteins will
be co-translationally solubilized. Pure detergents, mixed micelles,
micelles containing lipids, surfactants or amphipols could be sup-
plied in the D-CF mode, while in the L-CF mode lipid bilayers are
provided [3,53–58]. Overviews on the different types of artiﬁcial
hydrophobic environments including their particular properties
are given elsewhere [3,59].
Co-translational solubilization in either D-CF mode or L-CF
mode has an obvious impact on the translation kinetics of mem-
brane proteins. Whereas the synthesis of soluble proteins such as
GFP is not affected by the presence of supplied detergents or lipids,
the synthesis rate of membrane proteins is often notably reduced
[45]. Higher yields of membrane proteins can thus be obtained in
the P-CF mode without supplied hydrophobic compounds. The pre-
cipitates may retain folded structures and excessive refolding pro-
tocols are usually not applied for their subsequent solubilization
[60]. Depending on the membrane protein, a number of detergentssystem efﬁciency, e.g. the E. coli lysate quality, is monitored by GFP expression
hermore crucial. Expression depends on efﬁcient initiation of translation and can be
enesis of the ﬁrst natural 5’codons. Additional optional modiﬁcations include the
Fig. 5. Sample quality evaluation and reﬁnement of CF expression conditions. The three basic modes P-CF, D-CF and L-CF can be implemented either simultaneously or
sequentially. For each mode, numerous combinations of additives will be supplied and the quality of the resulting samples will be screened in appropriate assays.
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DDM are efﬁcient in solubilization. The P-CF synthesized MraY
translocase of Bacillus subtilis showed the highest speciﬁc activity
after solubilization in DDM [46]. Further functional or even high
resolution structural characterizations of P-CF generated mem-
brane protein samples have been exempliﬁed [15,31,47,61–64].
However, some membrane proteins may unfold irreversibly in
the P-CF mode [46]. The next step would thus be to switch to the
D-CF mode (Fig. 5). Systematic screens of detergents or surfactants
with deﬁned working concentrations that are tolerated by the CF
system have been published [3,65–69]. Most commonly used are
long chain Brij derivatives as well as peptide surfactants, digitonin,
the micelle forming short chain lipid di-heptanoyl-phosphocholine
or ﬂuorinated surfactants [16,61,69,70–74]. Suitable environments
are still hard to predict. The Agrobacterium curdlan synthase was
active after D-CF expression in peptide surfactants but not in Brij
derivatives [75], whereas numerous olfactory receptors showed
similar activity in peptide surfactants or in Brij detergents
[67,74]. High quality samples of the mitochondrial carrier Ucp1
were obtained with ﬂuorinated surfactants [69]. Screening mixed
micelles or micelles containing some lipids for better stability of
membrane proteins could further be advantageous [69]. The
NMR structure of proteorhodopsin as well as the crystal structure
of the eukaryotic Acetabularia rhodopsin II were obtained after
their D-CF expression in E. coli lysates in presence of digitonin
micelles containing some phosphocholines [16,17].
Membrane protein folding upon co-translational solubilization
can further be supported by providing stabilizing additives.
Addition of the all-trans retinal cofactor is required for thefunctional folding of rhodopsin derivatives [16,17,76]. The con-
trolled co-expression of individual subunits enabled and stabilized
the assembly of functional ATP synthase [15,77]. Redox systems
such as combinations of oxidized and reduced glutathione could
be beneﬁcial for the formation of disulﬁde bridges in eukaryotic
membrane proteins. Tightly binding small molecule ligands could
further help to support conformational stability e.g. during CF
expression G protein-coupled receptors (GPCRs) as already shown
in crystallization studies [78,79]. Efﬁcient strategies for extensive
post-translational modiﬁcations of membrane proteins in E. coli
lysates have so far not been developed and are still future perspec-
tives. The addition or co-expression of corresponding modifying
enzymes such as glycosyl transferases generally appears to be fea-
sible but still awaits further approval [80].5. Implementing bilayers: production of lipid dependent
membrane proteins
Lipids are the natural environment of membrane proteins and
are sometimes essential as stabilizing or even structural elements
[38,81,82]. In addition, some membrane proteins do not fold in
presence of detergents or do not even tolerate any contact with
detergents [46]. The L-CF mode implementing supplied mem-
branes as preformed liposomes, nanodiscs or as isolated micro-
somes is mandatory for these types of proteins (Fig. 5). However,
membrane protein insertion into bilayers is a different and less
efﬁcient process if compared with their solubilization in deter-
gents. Natural insertion machineries could be used by providing
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[2,83,84]. However, supplied artiﬁcial bilayers are devoid of any
proteins which is in contrast to the typically high protein to lipid
ratio of cellular membranes. This characteristic is most likely
advantageous for spontaneous insertion of membrane proteins as
artiﬁcial bilayers are then better accessible and provide more space
for insertion [34,71,85–88]. In addition, the speciﬁc topology of
artiﬁcial bilayers, e.g. the two-side access and the interface in
between membrane and membrane scaffold protein in nanodiscs
can further support membrane protein insertion. Providing some
detergent together with liposomes may further weaken bilayers
and promote insertion [89].
Well deﬁned and preformed bilayers can be added into CF reac-
tions either as liposomes or as nanodiscs (Fig. 6). In particular the
nanodisc technology provides excellent synergies to CF expression
[90,91]. Nanodiscs and liposomes of identical membrane composi-
tions differ signiﬁcantly in a number of properties. Nanodiscs are
stable and can be supplied in ﬁnal concentrations of at least
100 lM giving stoichiometric ratios even with highly expressing
membrane proteins. In contrast, pre-sized liposomes tend to fuse
during the reaction and might even precipitate [45].
Furthermore, nanodisc membranes and liposomes will have quite
different topologies with regard to membrane curvature, lateral
pressure and accessibility. Insertion of L-CF expressed GPCRs and
other membrane proteins was in particular efﬁcient with nan-
odiscs [42,76,92,93]. L-CF produced nanodisc complexes with
membrane proteins are highly soluble and suitable for many appli-
cations such as ligand binding studies or the characterization of
membrane protein oligomerization [42,94,95].
The selection of suitable membrane compositions is a crucial
point and lipid size, charge and resulting membrane topology are
important parameters for the membrane insertion and folding efﬁ-
ciency of membrane proteins (Fig. 6). The denaturation tempera-
ture of bacteriorhodopsin was shown to change signiﬁcantly with
the membrane composition [96]. Furthermore, the sterol content
of liposomes modulated the water permeability of inserted aqua-
porins [97]. Transition temperatures of the designed membranes
should always be below the usual CF reaction temperatures in
between 25 C and 35 C in order to facilitate protein insertion
[98]. Lateral pressure in the membrane depends on the lipid head-
groups as well as on the alkyl chain geometries and it is increased
by double bonds in cis conformation [99,100]. Spontaneous inser-
tion of membrane proteins into lipid bilayers is higher at lowFig. 6. Important lipid characteristics for the insertion and stabilization of membrane pro
headgroup, the length of the alkyl chain or saturation affect the ﬂuidity, thickness, charge
can have a further impact on protein folding, stabilization or activity.membrane elastic stress. Consequently, phosphocholine lipids or
even single chain lyso-phosphocholine lipids that reduce the cur-
vature stress could be more successful in promoting membrane
protein insertion in L-CF expression approaches. Negatively
charged headgroups of phosphoglycerol derivatives could further
improve membrane insertion and folding efﬁciency [101].
Accordingly, the functional folding of E. coli MraY translocase
enzymes responsible for bacterial cell wall precursor formation
was only observed after L-CF expression with nanodiscs assembled
with lipids containing phosphoglycerol headgroups [39].
6. The core application: functional studies with CF expressed
membrane proteins
Applications for the functional characterization of CF expressed
membrane proteins appear to be hardly limited and already cover
numerous examples of enzymes, pores, channels, transporters,
receptors as well as of fully assembled multi protein complexes
[1,5]. However, despite the common use of E. coli lysates, the indi-
vidual protocols for expression and processing differ signiﬁcantly
in view of the implemented expression mode, of the provided
hydrophobic environments and of the selection of supplemented
compounds. While high quality samples have been prepared out
of all three expression modes, the preferred selection strictly
depends on the requirements of the individual membrane protein
targets. In general, the P-CF and D-CF modes are more interesting
for structural studies, whereas the L-CF mode in combination with
liposomes or nanodiscs becomes important for the characteriza-
tion of lipid dependent activities of membrane proteins
[39,42,76,92,93].
Most current data are obtained from the characterization of CF
expressed rhodopsin derivatives, GPCRs, porins and channels as
well as of membrane integrated enzymes. Underlying reasons for
this selection bias are the availability of fast or highly sensitive
functional assays for these classes of membrane proteins such as
the folding dependent light absorption of rhodopsin derivatives
or the speciﬁc and high afﬁnity ligand binding of GPCRs. Those
assays are essential for the screening of suitable expression condi-
tions in a reasonable period as pointed out in the previous chap-
ters. A large variety of GPCRs synthesized in E. coli lysates have
been characterized. Most GPCRs have been D-CF expressed in pres-
ence of detergents [74,102–105], peptide surfactants [55,67,106]
or amphipol like substances [68]. Alternatively, P-CF expressionteins exempliﬁed on the basis of a nanodisc complex. Lipid properties such as type of
and lateral pressure of the bilayer. Direct lipid interaction with membrane proteins
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[103,107]. Even synthetic membranes built by diblock copolymers
could become a suitable expression environment for GPCRs [108].
Recent studies with the human endothelin receptors indicated that
L-CF expression into preformed nanodiscs could be a fast tool for
the subsequent characterization of GPCR/ligand interactions by
surface plasmon resonance techniques even in crude CF reaction
mixtures [42]. Alternatively, the direct insertion of CF expressed
GPCRs as well as of other membrane proteins into tethered lipid
bilayer membranes immobilized on chip surfaces could enable
future drug screening attempts [109–111].
7. Arising perspectives: structural studies with membrane
proteins
High success rates, rapid access to protein samples and efﬁcient
productivities make CF expression systems with E. coli lysates suit-
able for structural studies [112]. Seleno-methionine labeled sam-
ples of the multidrug transporter EmrE were a ﬁrst example of a
CF synthesized and crystallized membrane protein [113]. Only
low diffracting crystals were obtained with a human
voltage-dependent anion channel [114], whereas high resolution
crystal structures of D-CF expressed Acetabularia rhodopsin II
[17] and the P-CF expressed bacterial diacylglycerokinase DgkA
[18] were solved at 3.2 Å and at 2.28 Å, respectively. The structure
of DgkA was a proof-of principle study with a detailed comparison
of samples obtained either after P-CF expression or after inclusion
body production in E. coli cells. A comparable X-ray diffraction was
ﬁnally obtained with both samples [18].
NMR structural approaches proﬁt most from the labeling oppor-
tunities enabled by CF expression. Solution NMR spectra of CF syn-
thesized membrane proteins were obtained in different
hydrophobic environments such as detergents [52,115], amphipols
[116], nanodiscs [76] or bicelles [117]. The NMR structure of prote-
orhodopsin was solved with D-CF synthesized protein in presence
of optimized detergent mixtures [16]. Structures of a subunit of the
Alzheimer’s disease related protease presenilin-1, of membrane
integrated domains of various signal kinases and of several small
human integral membrane proteins were obtained with P-CF syn-
thesized samples [60,62,63]. Future drug screening approaches
based on combinations of NMR analysis of P-CF expressed mem-
brane proteins and molecular simulation could thus become feasi-
ble [118,119].
Structural dynamics is often crucial for protein–protein or pro-
tein–ligand interactions as well as for enzymatic catalysis or trans-
port cycles. Spectroscopic methods like NMR and EPR can provide
closer insights into these processes. Both techniques require label-
ing with spin probes or isotopes and pulsed EPR experiments like
PELDOR became the method of choice for the determination of
structural dynamics. Several dynamic features of membrane pro-
teins have been investigated by these methods in the last years
[120]. Protocols for labeling are available [120,121] and some
examples of in vivo expressed membrane proteins are the analysis
of the heterodimeric ABC transporter BmrCD [122] and the vitamin
transporter ButB [123]. Spin labeling is often performed with
lysine or cysteine speciﬁc coupling chemistry. First data of direct
spin label insertion via CF expression were obtained with the
incorporation of 57Fe into a soluble FeFe hydrogenase [124].
Protocols developed for the direct insertion of spin labels into CF
expressed soluble proteins could open the door for similar future
studies with membrane proteins [125].
Structural characterization by advanced single particle electron
microscopy techniques will come into focus in the near future
[126]. Well-resolved structures of larger assemblies such as the
CF synthesized 540kDa ATP–synthase complex of C. thermarum
can be obtained [15]. In addition, much lower amounts of samplesare required for electron microscopy and whole virus particles syn-
thesized in even mammalian lysates have been visualized [127].
The continuously increasing resolution of electron microscopy
could allow to analyze even smaller particles such as complexes
of membrane proteins in nanodiscs. Protein inserted into nan-
odiscs can be analyzed by atomic force microscopy as well as force
spectroscopy, revealing their native conformation [39,94]. The
evolving ﬁeld of native mass spectrometry of membrane proteins
and membrane protein complexes [128] especially in combination
with the nanodisc technology [129,130] gives a further promising
perspective for the characterization of CF expressed membrane
proteins.
8. Outlook and perspectives
E. coli lysates have already become the workhorse in the ﬁeld of
CF systems and the versatility of applications will continuously
grow. Evaluation of lysate blends combining beneﬁts of different
organisms is among the future developments and it will further
boost the production of difﬁcult biomolecules. Based on valuable
intrinsic features such as the cost-effective preparation of lysates,
the robustness and reliability of the translation machinery and
the immense accumulated knowledge in recombinant protein
expression, CF systems with E. coli lysates will further strengthen
their role as standard platform for preparative scale protein pro-
duction. Industrial scale applications such as the production of
antibody-drug conjugates and the design of hybrid biosynthetic
pathways with new and advanced properties in CF environments
are already emerging. CF expression completely re-designed mem-
brane protein production and the elimination of many restrictions
caused by the need to maintain cell viability opened numerous
new avenues of applications. Multitudes of chemically synthesized
compounds can now directly be used for the co-translational stabi-
lization of membrane proteins. The systematic screening of lipid
effects on membrane proteins by the combination of nanodiscs
with CF reactions is just one example for the excellent synergies
in this new ﬁeld of synthetic biology.
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